Breast cancer surgery after the COVID-19 pandemic
Data recently released by the UK Office for National Statistics shows a significant increase in the number of deaths compared with the previous 5-year average (2), and this is a direct consequence of COVID-19 and also the indirect impact of healthcare systems’ responses to managing the virus, includ...
Saved in:
Published in | Future Oncology Vol. 16; no. 33; pp. 2687 - 2690 |
---|---|
Main Authors | , , , |
Format | Journal Article Web Resource |
Language | English |
Published |
England
Future Medicine Ltd
01.11.2020
Future Science Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Data recently released by the UK Office for National Statistics shows a significant increase in the number of deaths compared with the previous 5-year average (2), and this is a direct consequence of COVID-19 and also the indirect impact of healthcare systems’ responses to managing the virus, including a reduction in cancer referral rates, a reduction in emergency attendances and the cancellation of elective surgery (3,4). Healthcare services have rapidly adapted by adopting remote or telephone consultations; deferring routine episodes such as screening survivorship patients and those with a high risk of developing breast cancer, those who have low-risk lesions, or those with noninvasive breast cancer; and halting longer exposure and resource-heavy procedures such as reconstructions and oncoplastic remodeling (7,8). To provide a framework for breast cancer specialists, professional bodies issued guidelines on risk stratification of essential breast cancer care based on tumor stage and biology and focused on identifying patients for whom surgery was time-critical or those for whom surgical intervention could be reasonably deferred for a period of time. Face-to-face consultations will require suitably sized clinic rooms to enable social distancing for the patient and clinician, availability of appropriate personal protective equipment, regular cleaning to follow national and local infection control guidelines and as access to systems for patients with additional needs such as disabilities and language interpreters. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 |
ISSN: | 1479-6694 1744-8301 |
DOI: | 10.2217/fon-2020-0619 |